Sharpe Jeffrey Nathan exercised Options for 500,000 Conexeu Sciences shares at $0.00 per share on Sept. 14, 2026. For investors, the disclosed ownership context includes 1,500,000 resulting shares, while the transaction represented about 33.3% of that holding and 50.0% of the prior derivative-securities holding.
Key Highlights
- Sharpe Jeffrey Nathan’s resulting Conexeu Sciences share holding was 1,500,000.
- The transaction represented about 33.3% of the resulting share holding.
- The post-transaction derivative-securities position was 500,000, equal to about 50.0% of the prior holding.
Sharpe Jeffrey Nathan exercised options for 500,000 Conexeu Sciences Inc. (NASDAQ: CNXU) shares at $0.00 per share on Sept. 14, 2026. The filing reports the share and derivative-securities holdings separately after the transaction.
Resulting Share and Derivative Holdings
After the exercise, Sharpe Jeffrey Nathan held 1,500,000 Conexeu Sciences shares. His reported derivative-securities holding stood at 500,000.
Reported Ownership Percentages
The 500,000-share exercise represented about 33.3% of Sharpe Jeffrey Nathan’s resulting 1,500,000-share holding. For derivative securities, the transaction represented about 50.0% of his prior derivative-securities holding.
FAQs
Q: What did Sharpe Jeffrey Nathan pay for the Conexeu Sciences option exercise?
A: The options were exercised at $0.00 per share. The transaction covered 500,000 Conexeu Sciences shares on Sept. 14, 2026. The filing identifies the transaction with SEC transaction code M.
Q: How many Conexeu Sciences shares did Sharpe Jeffrey Nathan own afterward?
A: Sharpe Jeffrey Nathan’s resulting Conexeu Sciences share holding was 1,500,000 after the transaction. The filing states that the transaction represented about 33.3% of his resulting share holding.
Q: What does transaction code M mean in this insider transaction?
A: Code M identifies an option exercise. The transaction also left Sharpe Jeffrey Nathan with 500,000 derivative securities, representing about 50.0% of his prior derivative-securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.